Known cancer genes DICER1, SMARCA4, CREBBP, and KMT2D, for instance, are among the top 35 genes ranked by PertInInt and contain significantly mutated interaction sites (combined score across interaction tracks > 6), each with several interaction sites that together harbor an enriched number of somatic mutations. This evidence concerns the gene KMT2D and cancer.